Series date: 
01/01/2024 - 8:00am EST to 12/31/2024 - 9:00am EST
Series location: 
PA
United States

Sessions

Session Date
Cancer: AHNCI Grand Rounds - "HER2 Positive Breast Cancer: 40 Years of Progress" - Session 1 - 01/09/2024 01/09/2024 - 8:00am to 9:00am EST
Cancer: AHNCI Grand Rounds - “Multiple Myeloma, Multiple Choices, How should we choose?” - Session 2 - 02/13/2024 02/13/2024 - 8:00am to 9:00am EST
Cancer: AHNCI Grand Rounds - “PARP inhibitors in prostate cancer – from BCR to mCRPC” -Session 3 - 03/12/2024 03/12/2024 - 8:00am to 9:00am EDT
Cancer: AHNCI Grand Rounds - “Management of HPV-related oropharyngeal cancers: The ORATOR trials, de-escalation, and beyond” - Session 4 - 04/09/2024 04/09/2024 - 8:00am to 9:00am EDT
Cancer: AHNCI Grand Rounds - “Esophageal Cancer, What We Know and Where We’re Going” - Session 5 - 05/14/2024 05/14/2024 - 8:00am to 9:00am EDT
Cancer: AHNCI Grand Rounds - "Hepatic Arterial Infusion Therapy" - Session 6 - 06/11/2024 06/11/2024 - 8:00am to 9:00am EDT
Cancer: AHNCI Grand Rounds -“Transformational Change in Rectal Cancer Treatment”- Session 7 - 07/09/2024 07/09/2024 - 8:00am to 9:00am EDT
Cancer: AHNCI Grand Rounds - “Is it Time to Reconsider our Treatment of Localized Esophageal Cancer?” - Session 8 - 08/13/2024 08/13/2024 - 8:00am to 9:00am EDT
Cancer: AHNCI Grand Rounds -“Radiotherapy for Glioblastoma on the MR-Linac: Adaptive Radiotherapy and Beyond”- Session 9 - 09/10/2024 09/10/2024 - 8:00am to 9:00am EDT
Cancer: AHNCI Grand Rounds -“Endometrial Cancer Updates and Building the ECMT2 Consortium” - Session 10 - 10/08/2024 10/08/2024 - 8:00am to 9:00am EDT

Pages